Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines
Microbial Pathogenesis · 2025-09 · 206 · 107786
DOI: 10.1016/j.micpath.2025.107786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025-09. Verfasst von Shinjini Bhattacharya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, 781039, Assam, India. Hauptthemen laut MEDLINE: Antiviral Agents, Cytokines, Piperazine, Herpesviridae Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Department of Health Research, India, Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, 781039, Assam, India.
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, 781039, Assam, India. Electronic address: sachinku@iitg.ac.in.
Förderung
- Department of Health Research, India
- Indian Council of Medical Research
Zitieren
APA
Bhattacharya, S., & Kumar, S. (2025). Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines. Microbial Pathogenesis, 206, 107786. https://doi.org/10.1016/j.micpath.2025.107786
Vancouver
Bhattacharya S, Kumar S. Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines. Microbial Pathogenesis. 2025;206:107786. doi:10.1016/j.micpath.2025.107786
BibTeX
@article{Bhattacharya2025,
author = {Bhattacharya, Shinjini and Kumar, Sachin},
title = {Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines},
journal = {Microbial Pathogenesis},
year = {2025},
volume = {206},
pages = {107786},
doi = {10.1016/j.micpath.2025.107786}
}
EUVIMED